Systemic Organ Communication in STEMI
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHeinrich-Heine University, Duesseldorf
About this trial
Despite progress in pre-hospital care, ambulance logistics, pharmacotherapy and PPCI techniques, ST-segment elevation myocardial infarction (STEMI) continues to confer a substantial burden of morbidity and mortality.
Within the STEMI population, there is a spectrum of higher and lower risk patients. The aim of this cohort study is to collect prospectively and systematically clinical research data from STEMI patients. This cohort study is an open-end observational study to identify master switches in myocardial ischemia.
Eligibility criteria
Qualifiers
Patients suffering from STEMI
Disqualifiers
< 18 years
Trial design
Treatments tested in this trial
- collection of clinical data
Treatment groups
No treatment groups listed
Locations
1Division of Cardiology, Pulmonary Disease and Vascular Medicine40225, Düsseldorf Germany
Sponsors and collaborators
Heinrich-Heine University, Duesseldorf
Lead sponsor
Source ClinicalTrials.gov